Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People’s Democratic Republic

Céline Caillet , Chanvilay Sichanh , Gaëtan Assemat , Myriam Malet-Martino (1) , Agnés Sommet (2) , Haleh Bagheri (3) , Noudy Sengxeu (4) , Niphonh Mongkhonmath , Mayfong Mayxay (5) , Lamphone Syhakhang , Maryse Lapeyre-Mestre (6) , Paul Newton (5) , Anne Roussin

1 SPCMIB - Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique
2 Service Pharmacologie Clinique [CHU Toulouse]
3 Unité de Pharmacoépidémiologie [CHU Toulouse]
4 NET - Neuroépidémiologie Tropicale
5 LOMWRU - Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit
6 LEASP - Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps

Domaines: Chimie

Céline Caillet, Chanvilay Sichanh, Gaëtan Assemat, Myriam Malet-Martino, Agnés Sommet, et al.. Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People’s Democratic Republic. Drug Safety, 2017, 40 (9), pp.809-821. ⟨10.1007/s40264-017-0544-z⟩. ⟨hal-02060426⟩